Ronald Moss's Email & Phone Number

💼 Past Experience

Ronald Moss has experience in a number of different roles within the Pharmaceutical and Biotech industries.Ronald Moss has a B.S. from the University of Utah in 1991. After completing his undergraduate studies,Ronald Moss pursued a medical degree from the University of Utah in 1994. He then completed a medical degree from Brigham and Women’s Hospital in 2000.Since 1993,Ronald Moss has been aVP Clinical Affairs, Senior Director Regulatory Affairs,VP Medical Affairs, and CEO,Phase 1 through NDA. At Aventis, Moss was responsible for the Global Regulatory Affairs Branch. Additionally, he was in charge of the Alliances and Cooperative Wholesalers Branch. At Immune Response, Moss was responsible for the Clinical Affairs Directorate. In his previous roles, Moss was also aVP Medical Affairs at Telos, VP Clinical Affairs at Vical, and also held numerous other positions in the Pharmaceutical and Biotech industries.Ronald Moss is currently CEO and President of NexBio Inc. Ron Moss played a significant role in the genesis and development of NexBio, Inc. NexBio is a 59% owned by Adamis Pharmaceuticals Corporation, a Fortune 500 specialty pharmaceutical company. Adamis Pharmaceuticals Corporation is a subsidiary of Valeant Pharmaceuticals International, Inc.

🎓 Education

Ronald Moss has a residency in Pediatrics from 1987 to 1990 at SUNY at Stony Brook University Hospital. He also has a Fellowship in Allergy and Immunology from 1990 to 1993 from the National Institutes of Health. From 1993 to 1997, he was an assistant professor of Pediatrics at the University of Illinois at Urbana-Champaign. From 1997 to 2000 he was a professor of Pediatrics at the University of Pittsburgh School of Medicine. From 2000 to 2002 he was a professor of Pediatrics at the University of Florence in Italy. Ronald Moss has been a doctor in the United States since 1984.

💡 Technical & Interpersonal Skills

Medical OfficerRonald Moss is currently a Medical Officer at Adamis Pharmaceuticals Corporation in San Deigo. He has been a CEO at Ansun BioPharma from February 2013 to February 2017 (4 years 1 month). He is also the interim CEO at NexBio, Inc from November 2011 to October 2012. Ron Moss has also been in executive positions at Aventis, Immune Response, Merck, Telos, Vical from 1994 to 2008. Ron Moss earned his medical degree from the University of California, San Diego.